Assessing harmful effects in systematic Reviews
Open Access
- 19 July 2004
- journal article
- review article
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 4 (1) , 19
- https://doi.org/10.1186/1471-2288-4-19
Abstract
Background: Balanced decisions about health care interventions require reliable evidence on harms as well as benefits. Most systematic reviews focus on efficacy and randomised trials, for which the methodology is well established. Methods to systematically review harmful effects are less well developed and there are few sources of guidance for researchers. We present our own recent experience of conducting systematic reviews of harmful effects and make suggestions for future practice and further research. Methods: We described and compared the methods used in three systematic reviews. Our evaluation focused on the review question, study designs and quality assessment. Results: One review question focused on providing information on specific harmful effects to furnish an economic model, the other two addressed much broader questions. All three reviews included randomised and observational data, although each defined the inclusion criteria differently. Standard methods were used to assess study quality. Various practical problems were encountered in applying the study design inclusion criteria and assessing quality, mainly because of poor study design, inadequate reporting and the limitations of existing tools. All three reviews generated a large volume of work that did not yield much useful information for health care decision makers. The key areas for improvement we identified were focusing the review question and developing methods for quality assessment of studies of harmful effects. Conclusions: Systematic reviews of harmful effects are more likely to yield information pertinent to clinical decision-making if they address a focused question. This will enable clear decisions to be made about the type of research to include in the review. The methodology for assessing the quality of harmful effects data in systematic reviews requires further development.Keywords
This publication has 14 references indexed in Scilit:
- Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluationHealth Technology Assessment, 2005
- Assessing the quality of researchBMJ, 2004
- Methodological index for non‐randomized studies (MINORS): development and validation of a new instrumentAnz Journal of Surgery, 2003
- Evaluating non-randomised intervention studiesHealth Technology Assessment, 2003
- Balancing benefits and harms in health careBMJ, 2003
- A systematic review of atypical antipsychotic drugs in schizophreniaHealth Technology Assessment, 2003
- Adverse drug reactions: keeping up to dateFundamental & Clinical Pharmacology, 2002
- The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluationHealth Technology Assessment, 2002
- Assessment of therapeutic safety in systematic reviews: literature reviewBMJ, 2001
- Completeness of Safety Reporting in Randomized TrialsJAMA, 2001